Total Funding
60
55
Total FundingPost-IPO Equity raised
Growth Score
-15 pts
Heat Score
6 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
34058
Semnur Pharmaceuticals is a specialty pharmaceutical company focusing on clinical and commercial development of innovative products.
Acquired by 
Sorrento Therapeutics
Mahendra G. Shah: Executive ChairmanPast Role: Globavir, Board of Directors
About the Company
Semnur Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the clinical and commercial development of innovative products that meet the needs of pain management practitioners and their patients.
